The Effect of Stevia Rebaudiana Extracts on Different Variables Related to Caries: an in Vitro and in Vivo Evaluation.
Launched by UNIVERSITÀ DEGLI STUDI DI SASSARI · Dec 22, 2012
Trial Information
Current as of August 22, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • good general health, normal salivary secretion rate, normal buffer capacity
- Exclusion Criteria:
- • systemic diseases, salivary secretion reduction, reduced buffer capacity
About Università Degli Studi Di Sassari
Università degli Studi di Sassari is a prominent academic institution located in Sardinia, Italy, dedicated to advancing medical research and education. With a strong focus on innovative clinical trials, the university collaborates with multidisciplinary teams to explore cutting-edge therapies and interventions across various medical fields. Its commitment to scientific excellence is underscored by a robust framework for ethical research practices and patient safety, ensuring that all clinical studies align with international standards. The university aims to contribute significantly to the advancement of healthcare knowledge and the improvement of patient outcomes through rigorous research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Laura Strohmenger, MD
Study Chair
WHO Collaborating Centre for Community Dentistry and Oral Epidemiology University of Milan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials